Consultants

Dr. Clare van Halsema is a Consultant in Infectious Diseases and serves as the HIV Service Lead and Clinical Lead for infectious diseases at North Manchester General Hospital. She has a longstanding clinical and research interest in HIV and tuberculosis (TB) co-infection.

Professional Background:

• Obtained a Diploma in Tropical Medicine and Hygiene (DTM&H) and an MSc in Epidemiology with distinction from the London School of Hygiene and Tropical Medicine.
• Worked with Médecins Sans Frontières in the Democratic Republic of Congo, focusing on antiretroviral therapy programs and inpatient HIV care.
• Conducted epidemiological studies on TB in people with HIV in South Africa, contributing to the Thibela TB study on community-wide isoniazid preventive therapy.

Current Roles:

• Clinical Lead for Infectious Diseases at North Manchester General Hospital.
• Lead for HIV service at North Manchester General Hospital.
• Trustee and member of the executive committee of the British HIV Association (BHIVA), chairing the guidelines subcommittee and participating in several guideline writing groups, including those focused on TB management.

Research Contributions:

• Authored 16 publications with 231 citations, covering topics such as antiretroviral therapy and HIV management. scispace.com
• Engaged in research evaluating long-acting injectable treatments for HIV infection. Dove Press
• British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non-tuberculous mycobacteria 2024. Nelson M, Bracchi M, Hunter E, Ong E, Pozniak A, van Halsema C.HIV Med. 2024 Dec;25 Suppl 4:3-25. doi: 10.1111/hiv.13727.
• UK guidelines for the investigation and management of eosinophilia in returning travellers and migrants. Thakker C, Warrell C, Barrett J, Booth HL, Chiodini PL, Defres S, Falconer J, Jacobs N, Jones J, Lambert J, Leong C, McBride A, Moore E, Moshiri T, Nabarro LE, O’Hara G, Stone N, van Halsema C, Checkley AM; British Infection Association.J Infect. 2025 Feb;90(2):106328. doi: 10.1016/j.jinf.2024.106328.
• British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical investigation and management of pyrexia of unknown origin 2023. van Halsema CL, Eades CP, Johnston VJ, Miller RF.HIV Med. 2023 Nov;24 Suppl 4:3-18. doi: 10.1111/hiv.13558.
• Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study. Fink DL, Callaby H, Luintel A, Beynon W, Bond H, Lim EY, Gkrania-Klotsas E, Heskin J, Bracchi M, Rathish B, Milligan I, O’Hara G, Rimmer S, Peters JR, Payne L, Mody N, Hodgson B, Lewthwaite P, Lester R, Woolley SD, Sturdy A, Whittington A, Johnson L, Jacobs N, Quartey J, Ai Payne B, Crowe S, Elliott IA, Harrison T, Cole J, Beard K, Cusack TP, Jones I, Banerjee R, Rampling T; Specialist and High Consequence Infectious Diseases Centres Network for Monkeypox; Dunning J.Lancet Infect Dis. 2023 May;23(5):589-597. doi: 10.1016/S1473-3099(22)00806-4.

Public Engagement:

• Active on social media platforms, sharing insights related to infectious diseases and public health. x.com

Dr. van Halsema’s extensive experience and leadership in infectious diseases, particularly in HIV and TB co-infection, contribute significantly to advancements in clinical care and public health initiatives.

GMC: 4511870